No Data
ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$905.44K in Common Stock
$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Lowenthal Richard E sold 100K shares of common stock on May 14, 15, 16, 2024 at an average price of $9.0544 for a total value of $905.44K. This transacti
Analysts Have Conflicting Sentiments on These Healthcare Companies: ARS Pharmaceuticals (SPRY), AnaptysBio (ANAB) and Allakos (ALLK)
ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns With EPS Projections Amidst Regulatory ...
ARS Pharmaceuticals First Quarter 2024 Earnings: US$0.11 Loss per Share (Vs US$0.16 Loss in 1Q 2023)
ARS Pharmaceuticals Unveils Updated Corporate Presentation
ARS Pharmaceuticals (SPRY.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $20,000; earnings per share of -0.11 dollars, previous value of -0.16 dollars, expected value of -0.11 dollars.
ARS Pharmaceuticals (SPRY.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $20,000; earnings per share of -0.11 dollars, previous value of -0.16 dollars, expected value of -0.11 dollars.